Event Information

Genetic Testing for Prostate Cancer

Type
Webinar

EVENT DETAILS

Display Date
Wednesday April 26, 2023 // 16:00-17:00 PT ◦ 19:00-20:00 ET ◦ 20:00-21:00 AT
Location
Virtual
Speaker
Michael Kolinsky, Ricardo Rendon, Shamini Selvarajah

ACCREDITATION

Accreditation
1 Section 1 Group Learning Credit
Event Description

OBJECTIVE:

  • Explain how the results of genetic testing in patients with prostate cancer can influence treatment decisions
  • Recognize patients for whom genetic testing should be ordered
  • Describe the familial cancer risks of hereditary gene alterations in patients with prostate cancer
  • Integrate genetic testing for patients with prostate cancer into their clinical practice

SPEAKERS:

Michael Kolinsky

Cross Cancer Institute and Department of Oncology
University of Alberta

Ricardo Rendon

Department of Urology, Dalhousie University
Queen Elizabeth II Health Sciences Centre

Shamini Selvarajah

Department of Clinical Laboratory Genetics, Laboratory Medicine Program, UHN
Department of Laboratory Medicine and Pathobiology, University of Toronto

REGISTER
Footer

SPONSOR:

sponsors

 

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy